On behalf of its member organizations, Biotechnology Innovation Organization (“BIO”) respectfully submits this Comment in response to the United States Patent and Trademark Office’s (the “Patent Office” or “PTO”) February 13, 2024 Request for…
BIO submits comments on the MDH’s proposed regulations regarding Drugs of Substantial Public Interest: Draft Methodology for Public Comment as required in statute by the Prescription Drug Price Transparency Act.
February 21, 2017: Coalition Budget Letter
March 9, 2017: James C. Greenwood Testimony on Farm Bill Rural Development & Energy Programs
October 19, 2017: BIO Letter to Congress on Biorefinery, Renewable Chemical, and Biobased Manufacturing Assistance Program
December 6, 2017: BIO, ASTA, USBC, BPIA and Humic Products Letter to Conaway on Biostimulants
February 6, 2018: IowaBio Farm Bill Energy Title Support Letter
March 6, 2018: National Farm Bill Energy Title Support Letter
April 12, 2018: Agriculture Energy Coalition Press Release on Farm Bill Energy Title Funding
April 17, 2018: Bio Nebraska Farm Bill Energy Title Support Letter
April 26, 2018: BIO, ASTA, USBC, BPIA and Humic Products Letter to Conaway on Biostimulants
June 12, 2018: Coalition Letter Farm Bill Ag Improvement Act
May 9, 2018: BIO, ASTA, USBC, BPIA and Humic Products to Roberts on Biostimulants
July 16, 2018: BIO Letter Farm Bill Conference Committee
August 13, 2018: Coalition Letter on Farm Bill Conference
August 24, 2018: National Ag Farm Bill Energy Title Letter
August 30, 2018: Agriculture Energy Coalition Letter on Farm Bill
October 9, 2018: BIO Oped on Farm Bill Energy Title in Biofuels Digest
October 15, 2018: Texas Energy Letter on Farm Bill Energy Title
October 18, 2018: Farm Bill Letter to Conference Committee
October 18, 2018: Farm Bill Letter to House/Senate Leadership
November 16, 2018: BIO Letter to Congresssional Leadership on Farm Bill